TRENDING

HEALTH

More news
Paxlovid is shown in an illustration in Medford

U.S. government to test Pfizer's Paxlovid for long COVID

The U.S. National Institutes of Health's $1 billion RECOVER Initiative has picked Pfizer Inc's antiviral drug Paxlovid as the first treatment it will study in patients with long COVID, organizers of the study said on Thursday.